Filters
Other countries
Results: 1 to 12 of 12
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
SmartMeds+ Pharmacogenomic Testing By Innovative GX Health Innovative Genomics InnovativeGx Health United States | 1 | 67 |
|
Eugenomic S.L. Spain | 1 | 16 |
|
Eugenomic S.L. Spain | 1 | 21 |
|
Lung cancer, resistance to, 211980, Autosomal recessive (MLPA) Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
CYP2A6 (CYP2A6 gene) (Sequence Analysis-All Coding Exons) (Postnatal) Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Nicotine addiction, protection from, 188890 (MLPA) Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Coumarin resistance, 122700, Autosomal dominant (MLPA) Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
MVZ diagnosticum Frankfurt MVZ diagnosticum GmbH Germany | 46 | 29 |
|
Fulgent Genetics United States | 3 | 1 |
|
Results: 1 to 12 of 12
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.